Effects of Achieving Rapid, Intensive, and Sustained Blood Pressure Reduction in Intracerebral Hemorrhage Expansion and Functional Outcome.

Neurology

From the Department of Neurology (D.R.-L., M.M., C.A.M.), Vall d'Hebron University Hospital; Stroke Research Group (D.R.-L., O.P., M.M., C.A.M.), Vall d'Hebron Research Institute; Department of Medicine (D.R.-L., O.P.), Autonomous University of Barcelona; Department of Neuroscience (L.L., S.R., A.C.), Comprehensive Stroke Center, Hospital Clinic, Barcelona; Department of Neurology (Y.S., M.T.), Hospital Universitari Dr. Josep Trueta, Girona; Department of Neurology (L.P.-S., A.R.-P.), Hospital de la Santa Creu i Sant Pau; Neurovascular Research Group (M.H.G.), Vall d'Hebron Research Institute; Department of Neuroradiology (P.C.), Vall d'Hebron University Hospital; Department of Interventional Neuroradiology (J.B.), CDI, Hospital Clínic; and Statistics and Bioinformatics Unit (S.P.-H.), Vall d'Hebron Research Institute, Barcelona, Spain.

Published: May 2024

Background And Objectives: The time taken to achieve blood pressure (BP) control could be pivotal in the benefits of reducing BP in acute intracerebral hemorrhage (ICH). We aimed to assess the relationship between the rapid achievement and sustained maintenance of an intensive systolic BP (SBP) target with radiologic, clinical, and functional outcomes.

Methods: Rapid, Intensive, and Sustained BP lowering in Acute ICH (RAINS) was a multicenter, prospective, observational cohort study of adult patients with ICH <6 hours and SBP ≥150 mm Hg at 4 Comprehensive Stroke Centers during a 4.5-year period. Patients underwent baseline and 24-hour CT scans and 24-hour noninvasive BP monitoring. BP was managed under a rapid (target achievement ≤60 minutes), intensive (target SBP <140 mm Hg), and sustained (target stability for 24 hours) BP protocol. SBP target achievement ≤60 minutes and 24-hour SBP variability were recorded. Outcomes included hematoma expansion (>6 mL or >33%) at 24 hours (primary outcome), early neurologic deterioration (END, 24-hour increase in NIH Stroke Scale score ≥4), and 90-day ordinal modified Rankin scale (mRS) score. Analyses were adjusted by age, sex, anticoagulation, onset-to-imaging time, ICH volume, and intraventricular extension.

Results: We included 312 patients (mean age 70.2 ± 13.3 years, 202 [64.7%] male). Hematoma expansion occurred in 70/274 (25.6%) patients, END in 58/291 (19.9%), and the median 90-day mRS score was 4 (interquartile range, 2-5). SBP target achievement ≤60 minutes (178/312 [57.1%]) associated with a lower risk of hematoma expansion (adjusted odds ratio [aOR] 0.43, 95% confidence interval [CI] 0.23-0.77), lower END rate (aOR 0.43, 95% CI 0.23-0.80), and lower 90-day mRS scores (aOR 0.48, 95% CI 0.32-0.74). The mean 24-hour SBP variability was 21.0 ± 7.6 mm Hg. Higher 24-hour SBP variability was not related to expansion (aOR 0.99, 95% CI 0.95-1.04) but associated with higher END rate (aOR 1.15, 95% CI 1.09-1.21) and 90-day mRS scores (aOR 1.06, 95% CI 1.04-1.10).

Discussion: Among patients with acute ICH, achieving an intensive SBP target within 60 minutes was associated with lower hematoma expansion risk. Rapid SBP reduction and stable sustention within 24 hours were related to improved clinical and functional outcomes. These findings warrant the design of randomized clinical trials examining the impact of effectively achieving rapid, intensive, and sustained BP control on hematoma expansion.

Classification Of Evidence: This study provides Class III evidence that in adults with spontaneous ICH and initial SBP ≥150 mm Hg, lowering SBP to <140 mm Hg within the first hour and maintaining this for 24 hours is associated with decreased hematoma expansion.

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000209244DOI Listing

Publication Analysis

Top Keywords

rapid intensive
12
intensive sustained
12
sbp target
12
hematoma expansion
12
achieving rapid
8
blood pressure
8
intracerebral hemorrhage
8
sbp
8
clinical functional
8
acute ich
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!